Physician profile
Eeka Marshall
NPI 1376856724
$14,395.17
in general payments reported to CMS, 2019-2025
8 companies · $6,131 in 2025
The $6,131 reported for 2025 was more than what 98% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $152 · 2021: $95.04 · 2022: $1,986 · 2024: $6,032 · 2025: $6,131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $6,000 · Education: $5,500 · Travel and Lodging: $602 · Food and Beverage: $60.86.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $6,000.00 |
| Education | $5,500.00 |
| Travel and Lodging | $601.67 |
| Food and Beverage | $60.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,989.82 | 2022-2025 | |
| Sonio | $6,000.00 | 2024 | |
| Therapeuticsmd, INC. | $114.49 | 2020 | |
| Mayne Pharma Commercial LLC | $109.41 | 2022 | |
| Abbvie INC. | $95.04 | 2021 | |
| Hologic Sales and Service, LLC | $53.42 | 2020-2024 | Novasure, Myosure Tissue Removal Device |
| Pfizer INC. | $17.44 | 2022 | |
| Merck Sharp & Dohme LLC | $15.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eeka Marshall listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.